October 31, 2007
en fr
Counterfeiting trends in the pharmaceutical industry

Photo by freepik on freepik

The Pharmaceutical Security Institute (PSI) has as its top priority, the protection of the public health through the disruption and dismantling of criminal groups involved in counterfeit pharmaceuticals. To that end the PSI works closely with the WCO, Customs administrations, other law enforcement agencies and drug regulatory authorities. While some sense of the global counterfeiting problem is conveyed by well publicised cases, too often the availability of counterfeiting data is limited even at times dubious, overly optimistic, very pessimistic, or highly questionable estimates are presented as fact.

To access the full text please

Additionally, for all newcomers we give 5 paid articles for free.

Comments ()

Forgot password?

* Mandatory fields

By signing up you agree to the Terms of Use and Privacy Policy

Password reset

Check your e-mail, we sent you a link to reset your password.


Login with Google Login with LinkedIn

Contact us

Thank you for report
Your email can be used only to contact you for problem details. It won't be used for advertising purposes
Maximum file size 6mb
File is too large